Cellectar Biosciences (CLRB)Chief Operating Officer bought ~$50K

~$50K

Approx. value · 10K sh @ $4.99

13K

Holds after · shares reported

Traded

Jul 2, 2025

Filed

Jul 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 2, 2025 · this disclosureInsiderOfficer purchased ~$50K of CLRB shares in the open market

What came next

1. Jul 2, 2025Insider · 2 peopleInsiders: 2 purchases (~$75K)
2. Oct 7, 2025Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 3 more items)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cellectar Biosciences

OQRO holds no insider, Congress, fund or contract record for Cellectar Biosciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CLRB page.

Other recent filings by Jarrod Longcor, Chief Operating Officer

• SEC Form 4 at Cellectar Biosciences (CLRB)May 12, 2026
• SEC Form 4 at Cellectar Biosciences (CLRB)Mar 13, 2025

The full history of Jarrod Longcor, Chief Operating Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cellectar Biosciences

• SEC Form 4May 12, 2026
• SEC Form 4May 12, 2026
• SEC Form 4Dec 16, 2025
• SEC Form 4Jul 3, 2025
• SEC Form 4Jul 3, 2025
• SEC Form 4Mar 13, 2025

Everything OQRO holds on this company is on its CLRB page.